Signaling pathways and therapeutic interventions in gastric cancer
Gastric cancer (GC) ranks fifth in global cancer diagnosis and fourth in cancer-related death.
Despite tremendous progress in diagnosis and therapeutic strategies and significant …
Despite tremendous progress in diagnosis and therapeutic strategies and significant …
[HTML][HTML] Korean practice guidelines for gastric cancer 2022: an evidence-based, multidisciplinary approach
TH Kim, IH Kim, SJ Kang, M Choi, BH Kim… - Journal of gastric …, 2023 - ncbi.nlm.nih.gov
Gastric cancer is one of the most common cancers in Korea and the world. Since 2004, this
is the 4th gastric cancer guideline published in Korea which is the revised version of …
is the 4th gastric cancer guideline published in Korea which is the revised version of …
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆
More than 1 million (1 089 103) new cases of gastric cancer were estimated globally in
2020, resulting in 768 793 deaths. 1 These burden estimates will continue to increase due to …
2020, resulting in 768 793 deaths. 1 These burden estimates will continue to increase due to …
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro …
X Zhang, H Liang, Z Li, Y Xue, Y Wang, Z Zhou… - The Lancet …, 2021 - thelancet.com
Background The optimal perioperative chemotherapeutic regimen for locally advanced
gastric cancer remains undefined. We evaluated the efficacy and safety of perioperative and …
gastric cancer remains undefined. We evaluated the efficacy and safety of perioperative and …
PRODIGY: a phase III study of neoadjuvant docetaxel, oxaliplatin, and S-1 plus surgery and adjuvant S-1 versus surgery and adjuvant S-1 for resectable advanced …
PURPOSE Adjuvant chemotherapy after D2 gastrectomy is standard for resectable locally
advanced gastric cancer (LAGC) in Asia. Based on positive findings for perioperative …
advanced gastric cancer (LAGC) in Asia. Based on positive findings for perioperative …
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally …
SE Al-Batran, N Homann, C Pauligk, TO Goetze… - The Lancet, 2019 - thelancet.com
Background Docetaxel-based chemotherapy is effective in metastatic gastric and gastro-
oesophageal junction adenocarcinoma. This study reports on the safety and efficacy of the …
oesophageal junction adenocarcinoma. This study reports on the safety and efficacy of the …
The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
FH Wang, XT Zhang, YF Li, L Tang, XJ Qu… - Cancer …, 2021 - Wiley Online Library
There exist differences in the epidemiological characteristics, clinicopathological features,
tumor biological characteristics, treatment patterns, and drug selections between gastric …
tumor biological characteristics, treatment patterns, and drug selections between gastric …
Updates on management of gastric cancer
FM Johnston, M Beckman - Current oncology reports, 2019 - Springer
Abstract Purpose of Review Gastric adenocarcinoma is the fifth most common and the third
most lethal cancer worldwide. Surgery is the only chance of cure, but recurrence is common …
most lethal cancer worldwide. Surgery is the only chance of cure, but recurrence is common …
Laparoscopic versus open gastrectomy for gastric cancer (LOGICA): a multicenter randomized clinical trial
A van der Veen, HJF Brenkman… - Journal of Clinical …, 2021 - ascopubs.org
BACKGROUND The oncological efficacy and safety of laparoscopic gastrectomy are under
debate for the Western population with predominantly advanced gastric cancer undergoing …
debate for the Western population with predominantly advanced gastric cancer undergoing …
[HTML][HTML] A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients …
SH Park, DH Lim, TS Sohn, J Lee, DY Zang, ST Kim… - Annals of …, 2021 - Elsevier
Background Adjuvant chemotherapy and chemoradiotherapy are some of the standards of
care for gastric cancer (GC). The Adjuvant chemoRadioTherapy In Stomach Tumors …
care for gastric cancer (GC). The Adjuvant chemoRadioTherapy In Stomach Tumors …